Skip to main content

G1 Therapeutics, Inc.

GTHXDelisted Sep 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001560241

G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding G1 Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of GTHX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders123114−9
Shares24.2M24.7M+499.6K (+2.1%)
Value$582.2M$541.8M−$40.3M (−6.9%)

New holders (11)

Institutions that held G1 Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to GTHX in Q2 2021
InstitutionSharesValue% of portfolio
Fisher Asset Management, LLC914,838$20.1M0.01%
Nordea Investment Management AB189,315$4.15M0.01%
Alps Advisors Inc55,417$1.22M0.01%
Jupiter Asset Management Ltd41,289$906.0K0.01%
Jump Financial, LLC33,902$744.0K0.07%
LPL Financial LLC10,305$226.0K0.00%
Squarepoint Ops LLC9,332$205.0K0.00%
FORA Capital, LLC2,045$45.0K0.01%
Advisory Services Network, LLC725$16.0K0.00%
Dark Forest Capital Management LP672$15.0K0.01%
Quantbot Technologies LP216$4.00K0.00%

Sold out (20)

Institutions that held G1 Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.